Objectives: To identify ribosome protein L5 gene variants and the risk of hepatic vein thrombosis in Saudi patients.
Methods: A case-control study was conducted during the period of May 2018 to September 2019. Sixty-five patient cases of hepatic vein thrombosis (HVT) were chosen, and 50 healthy individuals of the same ages and both gender were set as a control group.